To explore this, we added an anti-albumin VHH to the EGFR-Vδ2hi-lo bsVHH (see Supplementary Figure S4A for design) and confirmed binding to both Vγ9Vδ2 T-cells and EGFR+ tumor cells (Supplementary Figure S4B). This evidence concerns the gene EGFR and neoplasm.